These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

810 related articles for article (PubMed ID: 20839032)

  • 1. CXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progression.
    Sun X; Cheng G; Hao M; Zheng J; Zhou X; Zhang J; Taichman RS; Pienta KJ; Wang J
    Cancer Metastasis Rev; 2010 Dec; 29(4):709-22. PubMed ID: 20839032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CXCR7 as a novel therapeutic target for advanced prostate cancer.
    Gritsina G; Yu J
    Oncogene; 2023 Mar; 42(11):785-792. PubMed ID: 36755058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the CXCR4/CXCR7/CXCL12 Axis in Primary Desmoid Tumors.
    Baccalini EA; Renne SL; Colombo P; Pasqualini F; Quagliuolo VL; Cananzi FCM; Grizzi F; Borroni EM
    Anticancer Agents Med Chem; 2023; 23(20):2248-2253. PubMed ID: 36748819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. G protein‑mediated EGFR transactivation is a common mechanism through which the CXCL12 receptors, CXCR4 and CXCR7, control human cancer cell migration.
    Zieger-Naumann K; Kuhl F; Engele J
    Oncol Rep; 2024 Feb; 51(2):. PubMed ID: 38099418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CXCL12 enhances human neural progenitor cell survival through a CXCR7- and CXCR4-mediated endocytotic signaling pathway.
    Zhu B; Xu D; Deng X; Chen Q; Huang Y; Peng H; Li Y; Jia B; Thoreson WB; Ding W; Ding J; Zhao L; Wang Y; Wavrin KL; Duan S; Zheng J
    Stem Cells; 2012 Nov; 30(11):2571-83. PubMed ID: 22987307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crosstalk between CXCL12/CXCR4/ACKR3 and the STAT3 Pathway.
    Ma Z; Zhou F; Jin H; Wu X
    Cells; 2024 Jun; 13(12):. PubMed ID: 38920657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stromal cell-derived factor-1 exerts opposing roles through CXCR4 and CXCR7 in angiotensin II-induced adventitial remodeling.
    Song B; Chen D; Liu Z; Cheng Y; Zhang Z; Han W; Zhang R; Gong Y
    Biochem Biophys Res Commun; 2022 Feb; 594():38-45. PubMed ID: 35066378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions of the chemokines CXCL11 and CXCL12 in human tumor cells.
    Koch C; Fischer NC; Puchert M; Engele J
    BMC Cancer; 2022 Dec; 22(1):1335. PubMed ID: 36539774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting CXCL12/CXCR4 Axis in Tumor Immunotherapy.
    Zhou W; Guo S; Liu M; Burow ME; Wang G
    Curr Med Chem; 2019; 26(17):3026-3041. PubMed ID: 28875842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The contributory roles of the CXCL12/CXCR4/CXCR7 axis in normal and malignant hematopoiesis: A possible therapeutic target in hematologic malignancies.
    Mehrpouri M
    Eur J Pharmacol; 2022 Apr; 920():174831. PubMed ID: 35183534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CXCL12-CXCR4/CXCR7 Axis in Cancer: from Mechanisms to Clinical Applications.
    Yang Y; Li J; Lei W; Wang H; Ni Y; Liu Y; Yan H; Tian Y; Wang Z; Yang Z; Yang S; Yang Y; Wang Q
    Int J Biol Sci; 2023; 19(11):3341-3359. PubMed ID: 37497001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tamoxifen as a modulator of CXCL12-CXCR4-CXCR7 chemokine axis: A breast cancer and glioblastoma view.
    Gonçalves TL; de Araújo LP; Pereira Ferrer V
    Cytokine; 2023 Oct; 170():156344. PubMed ID: 37639844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-X-C motif chemokine ligand 12 (CXCL12)/C-X-C motif chemokine receptor 7(CXCR7) regulates epithelial-mesenchymal transition process and promotes the metastasis of esophageal cancer by activating signal transducer and activator of transcription 3 (STAT3) pathway.
    Guo J; Tong CY; Shi JG; Li XJ
    Bioengineered; 2022 Mar; 13(3):7425-7438. PubMed ID: 35264069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CXCR7/CXCL12 axis is involved in lymph node and liver metastasis of gastric carcinoma.
    Xin Q; Zhang N; Yu HB; Zhang Q; Cui YF; Zhang CS; Ma Z; Yang Y; Liu W
    World J Gastroenterol; 2017 May; 23(17):3053-3065. PubMed ID: 28533662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular insights into intrinsic transducer-coupling bias in the CXCR4-CXCR7 system.
    Sarma P; Carino CMC; Seetharama D; Pandey S; Dwivedi-Agnihotri H; Rui X; Cao Y; Kawakami K; Kumari P; Chen YC; Luker KE; Yadav PN; Luker GD; Laporte SA; Chen X; Inoue A; Shukla AK
    Nat Commun; 2023 Aug; 14(1):4808. PubMed ID: 37558722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential Application of Leelamine as a Novel Regulator of Chemokine-Induced Epithelial-to-Mesenchymal Transition in Breast Cancer Cells.
    Jung YY; Um JY; Sethi G; Ahn KS
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CXCR4-CXCL12-CXCR7 and PD-1/PD-L1 in Pancreatic Cancer: CXCL12 Predicts Survival of Radically Resected Patients.
    D'Alterio C; Giardino A; Scognamiglio G; Butturini G; Portella L; Guardascione G; Frigerio I; Montella M; Gobbo S; Martignoni G; Napolitano V; De Vita F; Tatangelo F; Franco R; Scala S
    Cells; 2022 Oct; 11(21):. PubMed ID: 36359736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microfluidic platform for chemotaxis in gradients formed by CXCL12 source-sink cells.
    Torisawa YS; Mosadegh B; Bersano-Begey T; Steele JM; Luker KE; Luker GD; Takayama S
    Integr Biol (Camb); 2010 Nov; 2(11-12):680-6. PubMed ID: 20871938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An emerging paradigm of CXCL12 involvement in the metastatic cascade.
    Anastasiadou DP; Quesnel A; Duran CL; Filippou PS; Karagiannis GS
    Cytokine Growth Factor Rev; 2024 Feb; 75():12-30. PubMed ID: 37949685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of the CXCL12/CXCR4/CXCR7 Chemokine Axis in Cancer.
    Shi Y; Riese DJ; Shen J
    Front Pharmacol; 2020; 11():574667. PubMed ID: 33363463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.